Standard cancer therapies utilize surgery, chemotherapy, and radiation to attack and kill cancer tumors. While survival rates have improved over the years, cancer remains one of the largest threats to public health, particularly in South Carolina, which has high rates of breast, colon, lung, and prostate cancer. The Center for Cancer Stem Cell Biology and Therapy Center of Economic Excellence (CoEE) seeks to improve cancer outcomes by developing new therapeutic options for killing cancer stem cells, including stem cell replacement.
The research focus of this Center is two-fold: first, identify ways to use stem cells found in bone marrow or adult organs as treatment targets for cancer therapy; second, develop and market the bioengineering aspects of stem cell collection and utilization for more functional, adaptable clinical applications. The Center for Cancer Stem Cell Biology and Therapy is currently recruiting endowed chairs in translational biomedical science for cancer cellular research and in cancer biomedical engineering.
For more information, visit http://hcc.musc.edu
A new promising new frontier in cancer research: the role of stem cells. Learn More
RBC Insurance awards $100,000 grant to Hollings Cancer Center. Learn More